1 Oncternal Therapeutics Inc Receivables Turnover Ratio (ONCT), from the third quarter 2024 to the third quarter 2023 current and historic results, rankings and more - CSIMarket

Company Name, Ticker, Industry, else..

Growth Rates

Profitability

Valuation Comparisons

Management Effectiveness

Financial Strength

Efficiency

• Sales per Employee

• Income per Employee

• Inventory Turnover

• Asset Turnover

• Receivables Turnover

Dividend Comparisons

Oncternal Therapeutics Inc (NASDAQ: ONCT)

Sector • Healthcare Industry • Major Pharmaceutical Preparations

Industry • Major Pharmaceutical Preparations

Sector • Healthcare

Oncternal Therapeutics Inc Accounts Receivables Turnover Ratio from the third quarter 2024 to the third quarter 2023

Quarterly Results, Trends, Rankings, Statistics

According to Oncternal Therapeutics Inc Balance Sheet, in the third quarter 2024, company has not reported any Accounts receivable.
See Oncternal Therapeutics Inc Balance Sheet

If we take a look into Healthcare sector 510 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2024 from 3267 to 3340.

What is Receivable Turnover Ratio?
What is Oncternal Therapeutics Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ONCT Receivables Turnover Ratio	(Sep 30 2024) III. Quarter	(Jun 30 2024) II. Quarter	(Mar 31 2024) I. Quarter	(Dec 31 2023) IV. Quarter	(Sep 30 2023) III. Quarter
Y / Y Receivable Change	-	-	-	-	-
Y / Y Revenue Change	175.98 %	655.66 %	180.3 %	73.68 %	-53.14 %
Receivable Turnover Ratio (TTM)	-	-	-	-	-
ONCT's Total Ranking	# 3340	# 3267	# 3266	# 3237	# 3266
Accounts Receivable average collection period days	-	-	-	-	-
Seq. Receivable Change	-	-	-	-	-
Seq. Revenue Change	-38.33 %	40.77 %	91.58 %	65.92 %	68.87 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 180
Healthcare Sector	# 511
Overall Market	# 3340

Receivable Turnover Ratio Statistics
High	Average	Low
0.15	0.05	0
(Sep 30 2020)		(Dec. 30, 2015)

ONCT Company Profile • Back to ONCT Efficiency Comparisons • Compare ONCT Receivables Turnover Ratio to its Competitors

Financial Statements
Oncternal Therapeutics Inc 's Accounts Receivable	$ 0 Millions	Visit ONCT's Balance sheet
Oncternal Therapeutics Inc 's Sales TTM	$ 2 Millions	Visit ONCT's Income Statement
Sources of ONCT's Revenues		Visit ONCT's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ONCT's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ONCT's Growth Rates	ONCT's Roa	ONCT's Inventory Turnover Ratio	ONCT's Dividend Comparisons
ONCT's Profitability Ratios	ONCT's Roi	ONCT's Asset Turnover Ratio	ONCT's Dividend Growth
ONCT's Valuation Ratios	ONCT's Roe	ONCT's Financial Strength Ratios	ONCT's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2024, within Healthcare Sector

Receivable Turnover Ratio

Revenues for 12 Months ending Sep 30 2024

Receivable at quarter ending Sep 30 2024

Date modified: 2026-08-29T17:34:56+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.